PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL)

Q: What does CUSIP 74019P207 represent in this 13F holders report?

CUSIP 74019P207 is the security identifier for DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share used to aggregate holder disclosures.

Q: How many institutions held DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share in Q2 2024?

45 institutional investors reported DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share for Q2 2024. Use the holders table for investor-level position and value details.

CUSIP: 74019P207

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class: Equity / Common Stock, $0.000005 par value per share
Shares outstanding: 25,804,443
Total 13F shares: 3,161,323
Share change: -2,820
Total reported value: $30,774,875
Price per share: $9.73
Number of holders: 45
Value change: -$108,215
Number of buys: 17
Number of sells: 17

Quarterly Holders Quick Answers

What is CUSIP 74019P207?
CUSIP 74019P207 identifies DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2024
Previous quarter: Q1 2024

Recent filing periods for CUSIP 74019P207:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of DTIL - PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
TANG CAPITAL MANAGEMENT LLC	13F	Company	2.3%	589,569	$7,994,555	—	31 Mar 2024	13F
JANUS HENDERSON GROUP PLC	13F	Company	2.2%	573,052	$7,739,067	—	31 Mar 2024	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.9%	480,483	$6,515,349	—	31 Mar 2024	13F
Aquilo Capital Management, LLC	13F	Company	1.5%	385,440	$5,226,566	—	31 Mar 2024	13F
NOVARTIS PHARMA AG	3/4/5	10%+ Owner	— class O/S missing	12,407,440	$4,590,753	—	15 Jun 2022	3/4/5
VANGUARD GROUP INC	13F	Company	1%	260,831	$3,536,868	—	31 Mar 2024	13F
Alyeska Investment Group, L.P.	13F	Company	0.97%	250,000	$3,390,000	—	31 Mar 2024	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.44%	114,272	$1,548,000	—	31 Mar 2024	13F
Derek Jantz	3/4/5	Chief Scientific Officer, Director	— mixed-class rows	4,079,565 mixed-class rows	$1,509,439	—	07 Jun 2022	3/4/5
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.39%	99,498	$1,349,000	—	31 Mar 2024	13F
CITADEL ADVISORS LLC	13F	Company	0.38%	97,275	$1,319,049	—	31 Mar 2024	13F
Matthew R. Kane	3/4/5	President and CEO, Director	— mixed-class rows	2,026,513 mixed-class rows	$749,324	—	07 Jun 2021	3/4/5
Moloney Securities Asset Management, LLC	13F	Company	0.21%	54,199	$734,938	—	31 Mar 2024	13F
STIFEL FINANCIAL CORP	13F	Company	0.15%	39,871	$540,650	—	31 Mar 2024	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.12%	29,843	$404,767	—	31 Mar 2024	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.11%	28,413	$385,280	—	31 Mar 2024	13F
BlackRock Finance, Inc.	13F	Company	0.1%	26,402	$358,011	—	31 Mar 2024	13F
Tejara Capital Ltd	13F	Company	0.1%	24,767	$335,841	—	31 Mar 2024	13F
Blue Owl Capital Holdings LP	13F	Company	0.08%	20,220	$274,183	—	31 Mar 2024	13F
Samuel C. Wadsworth	3/4/5	Director	— mixed-class rows	14,028 mixed-class rows	$161,277	—	04 Jun 2024	3/4/5
Corient Private Wealth LLC	13F	Company	0.05%	11,881	$161,106	—	31 Mar 2024	13F
MORGAN STANLEY	13F	Company	0.05%	11,759	$159,452	—	31 Mar 2024	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.04%	11,546	$156,564	—	31 Mar 2024	13F
Curi Capital, LLC	13F	Company	0.04%	11,333	$153,676	—	31 Mar 2024	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.04%	10,067	$137,000	—	31 Mar 2024	13F
JPMORGAN CHASE & CO	13F	Company	0.03%	8,516	$115,476	—	31 Mar 2024	13F
Amundi	13F	Individual	0.03%	8,521	$91,345	—	31 Mar 2024	13F
Allworth Financial LP	13F	Company	0.02%	4,769	$64,668	—	31 Mar 2024	13F
Vivo Capital, LLC	13F	Company	0.02%	4,675	$63,395	—	31 Mar 2024	13F
Alan List	3/4/5	Chief Medical Officer	— mixed-class rows	5,469 mixed-class rows	$56,440	—	01 May 2024	3/4/5
David S. Thomson	3/4/5	Chief Operating Officer	— mixed-class rows	130,768 mixed-class rows	$41,260	—	23 Jun 2021	3/4/5
BARCLAYS PLC	13F	Company	0.01%	2,873	$38,958	—	31 Mar 2024	13F
OSAIC HOLDINGS, INC.	13F	Company	0.01%	1,895	$25,695	—	31 Mar 2024	13F
Shane Barton	3/4/5	VP & Corporate Controller	— mixed-class rows	33,562 mixed-class rows	$12,418	—	07 Jun 2023	3/4/5
WELLS FARGO & COMPANY/MN	13F	Company	0%	861	$11,674	—	31 Mar 2024	13F
Fayaz Khazi	3/4/5	CEO of Elo Life Systems	— mixed-class rows	65,239 mixed-class rows	$8,880	—	07 Jun 2021	3/4/5
Tower Research Capital LLC (TRC)	13F	Company	0%	389	$5,275	—	31 Mar 2024	13F
Zurcher Kantonalbank (Zurich Cantonalbank)	13F	Company	0%	353	$4,787	—	31 Mar 2024	13F
UBS Group AG	13F	Company	0%	206	$2,793	—	31 Mar 2024	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	152	$2,061	—	31 Mar 2024	13F
TOTH FINANCIAL ADVISORY CORP	13F	Company	0%	100	$1,356	—	31 Mar 2024	13F
NewEdge Advisors, LLC	13F	Company	0%	48	$644	—	31 Mar 2024	13F
Ameliora Wealth Management Ltd.	13F	Company	0%	33	$447	—	31 Mar 2024	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0%	14	$190	—	31 Mar 2024	13F
Investors Research Corp	13F	Company	0%	8	$108	—	31 Mar 2024	13F
Qube Research & Technologies Ltd	13F	Company	0%	5	$68	—	31 Mar 2024	13F
FMR LLC	13F	Company	0%	2	$27	—	31 Mar 2024	13F
CITIGROUP INC	13F	Company	0%	1	$14	—	31 Mar 2024	13F
GPS Wealth Strategies Group, LLC	13F	Company	0%	1	$14	—	31 Mar 2024	13F
Raymond F. Schinazi	3/4/5	Director	— class O/S missing	156,951	—	—	10 May 2022	3/4/5

Institutional Holders of PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL) as of Q2 2024

As of 30 Jun 2024, PRECISION BIOSCIENCES INC - Common Stock, $0.000005 par value per share (DTIL) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,161,323 shares. The largest 10 holders included JANUS HENDERSON GROUP PLC, TANG CAPITAL MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, Aquilo Capital Management, LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., ACADIAN ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, and BlackRock Inc.. This page lists 45 institutional shareholders reporting positions in this security for the Q2 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Q2 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q1 2024 Value $	Q2 2024 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.